HomeArticlesPhysics & Mechanics

The Human Microbiome: How Trillions of Microbes Shape Our Health

The gut microbiome's role in immunity, mental health, obesity, and disease: latest research on probiotics, fecal transplants, and engineered microbes.

mysimulator teamUpdated June 2026≈ 3 min read▶ Open the simulation

The Microbial Universe Inside You

The human body hosts ~38 trillion microorganisms (bacteria, archaea, fungi, viruses) — roughly equal to the number of human cells. The gut microbiome: 500-1,000 species, dominated by Firmicutes and Bacteroidetes phyla. Collective microbial genome: 3.3 million genes (vs. ~20,000 human genes) — the "second genome." Key functions: digestion of complex carbohydrates (fiber → short-chain fatty acids like butyrate, propionate, acetate), vitamin synthesis (K, B12, folate, biotin), immune system development, pathogen resistance (colonization resistance). Human Microbiome Project (NIH, 2007-2016): mapped the "healthy" microbiome across body sites. MetaHIT (EU): metagenomic analysis of gut microbiomes. Microbiome composition is established by age 3 and remains relatively stable, but is influenced by diet, antibiotics, environment, and genetics.

Microbiome and Disease

Obesity: obese individuals have reduced microbial diversity and altered Firmicutes/Bacteroidetes ratio. Germ-free mice colonized with obese microbiome gain more weight than those colonized with lean microbiome. Inflammatory bowel disease (IBD): Crohn's disease and ulcerative colitis associated with reduced diversity and loss of anti-inflammatory species (Faecalibacterium prausnitzii). Type 2 diabetes: gut dysbiosis affects glucose metabolism through SCFA production and bile acid modification. Cancer: H. pylori → stomach cancer, Fusobacterium nucleatum enriched in colorectal tumors, microbiome influences immunotherapy response (PD-1 responders have more Akkermansia muciniphila). Autoimmunity: molecular mimicry — microbial proteins resembling self-antigens may trigger rheumatoid arthritis, MS, type 1 diabetes. Allergies and asthma: the "hygiene hypothesis" — reduced microbial exposure in childhood increases allergy risk. C-section vs. vaginal birth: different initial colonization patterns with long-term health implications.

жива демонстрація · пов'язана симуляція● LIVE

Gut-Brain Axis

The gut-brain axis: bidirectional communication via vagus nerve, immune molecules, hormones, and microbial metabolites. 90% of serotonin is produced in the gut — not the brain. GABA, dopamine, and norepinephrine are also produced by gut bacteria. Germ-free mice: increased anxiety, altered stress responses (HPA axis), reduced BDNF levels — normalized by microbial colonization. Psychobiotics: specific probiotics that influence mental health — Lactobacillus rhamnosus reduced anxiety in mice via vagus nerve. Human studies: gut microbiome composition correlates with depression severity (Valles-Colomer et al., Nature Microbiology 2019). Parkinson's disease: gut symptoms often precede motor symptoms by years, α-synuclein pathology may spread from gut to brain. Alzheimer's: gut dysbiosis, increased intestinal permeability ("leaky gut"), and neuroinflammation linked. Autism spectrum disorder: altered gut microbiome consistently reported, fecal transplant studies show symptom improvement in small trials.

Therapeutics and the Future

Fecal Microbiota Transplant (FMT): FDA-approved Rebyota (2022) and Vowst (2023) for recurrent C. difficile infection — 70-90% cure rate. FMT delivers a complete, diverse microbial community from a healthy donor. Next-generation probiotics: defined consortia of specific strains (SER-109 — 11 Firmicutes strains for C. diff). Engineered probiotics: bacteria designed to produce therapeutic molecules in the gut (Synlogic, Novome). Postbiotics: microbial metabolites (SCFAs, indole derivatives) as drugs. Precision nutrition: microbiome-based dietary recommendations (DayTwo, Zoe). Fiber and prebiotics: inulin, GOS, resistant starch — selectively feed beneficial bacteria. Phage therapy: bacteriophages targeting specific pathogenic bacteria while sparing commensals. Challenges: inter-individual variability (everyone's microbiome is unique), causation vs. correlation (most associations are correlational, not proven causal), standardization of FMT. Future: personalized microbiome therapeutics, infant microbiome seeding for C-section babies, microbiome-aware drug prescription.

Try it live

Everything above runs in your browser — open SPH Fluid and change the parameters while it is running. Nothing is installed, nothing is uploaded, the whole model lives in one tab.

▶ Open SPH Fluid simulation

What did you find?

Add reproduction steps (optional)